LEVY RALPH E 4
4 · SANGSTAT MEDICAL CORP · Filed Sep 15, 2003
Insider Transaction Report
Form 4
LEVY RALPH E
SVP Operations
Transactions
- Exercise/Conversion
Common Stock
2003-09-11$12.99/sh+3,019$39,217→ 3,019 total - Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−6,250$140,625→ 0 total - Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−24,790$557,775→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$19.38/sh+2,299$44,555→ 2,299 total - Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−10,210$229,725→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$10.75/sh+6,250$67,188→ 6,250 total - Exercise/Conversion
Common Stock
2003-09-11$10.20/sh+8,022$81,849→ 8,022 total - Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−2,299$51,728→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$10.20/sh+16,978$173,228→ 16,978 total - Exercise/Conversion
Common Stock
2003-09-11$19.38/sh+25,701$498,085→ 25,701 total - Exercise/Conversion
Common Stock
2003-09-11$8.07/sh+24,790$200,055→ 24,790 total - Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−8,022$180,495→ 0 total - Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−16,978$382,005→ 0 total - Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−10,481$235,823→ 0 total - Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−25,701$578,273→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$12.99/sh+10,481$136,148→ 10,481 total - Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−3,019$67,928→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$8.07/sh+10,210$82,395→ 10,210 total
Footnotes (1)
- [F1]Option vesting was accelerated and the resulting common stock from the exercise and all outstanding common stock was acquired by Genzyme Corporation ("Genzyme") pursuant to the Agreement and Plan of Merger by and among Genzyme, Swift Starboard Corporation and SangStat Medical Corporation.